An Evaluation of the Accuracy of the Subtraction Method Used for Determining Platelet Counts in Advanced Platelet-Rich Fibrin and Concentrated Growth Factor Preparations
- PMID: 29563413
- PMCID: PMC5806990
- DOI: 10.3390/dj5010007
An Evaluation of the Accuracy of the Subtraction Method Used for Determining Platelet Counts in Advanced Platelet-Rich Fibrin and Concentrated Growth Factor Preparations
Abstract
Platelet concentrates should be quality-assured of purity and identity prior to clinical use. Unlike for the liquid form of platelet-rich plasma, platelet counts cannot be directly determined in solid fibrin clots and are instead calculated by subtracting the counts in other liquid or semi-clotted fractions from those in whole blood samples. Having long suspected the validity of this method, we herein examined the possible loss of platelets in the preparation process. Blood samples collected from healthy male donors were immediately centrifuged for advanced platelet-rich fibrin (A-PRF) and concentrated growth factors (CGF) according to recommended centrifugal protocols. Blood cells in liquid and semi-clotted fractions were directly counted. Platelets aggregated on clot surfaces were observed by scanning electron microscopy. A higher centrifugal force increased the numbers of platelets and platelet aggregates in the liquid red blood cell fraction and the semi-clotted red thrombus in the presence and absence of the anticoagulant, respectively. Nevertheless, the calculated platelet counts in A-PRF/CGF preparations were much higher than expected, rendering the currently accepted subtraction method inaccurate for determining platelet counts in fibrin clots. To ensure the quality of solid types of platelet concentrates chairside in a timely manner, a simple and accurate platelet-counting method should be developed immediately.
Keywords: concentrated growth factors; fractionation; platelet-rich fibrin; platelets; quality assurance; regenerative therapy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








References
-
- Castro A.B., Meschi N., Temmerman A., Pinto N., Lambrechts P., Teughels W., Quirynen M. Regenerative potential of Leucocyte- and Platelet Rich Fibrin (L-PRF). Part B: Sinus floor elevation, alveolar ridge preservation, and implant therapy. A systematic review. J. Clin. Periodontol. 2016 doi: 10.1111/jcpe.12658. - DOI - PMC - PubMed
-
- Castro A.B., Meschi N., Temmerman A., Pinto N., Lambrechts P., Teughels W., Quirynen M. Regenerative potential of leucocyte- and platelet-rich fibrin. Part A: Intra-bony defects, furcation defects and periodontal plastic surgery. A systematic review and meta-analysis. J. Clin. Periodontol. 2016 doi: 10.1111/jcpe.12643. - DOI - PMC - PubMed
-
- Hehn J., Schwenk T., Striegel M., Schlee M. The effect of PRF (platelet-rich fibrin) inserted with a split-flap technique on soft tissue thickening and initial marginal bone loss around implants: Results of a randomized, controlled clinical trial. Int. J. Implant Dent. 2016;2 doi: 10.1186/s40729-016-0044-4. - DOI - PMC - PubMed
-
- Okuda K., Nakajima Y., Kawase T., Kobayashi M., Kamiya M., Wolff L., Yoshie H. Platelet-rich fibrin membrane combined with beta-tricalcium phosphate for treatment of infrabony defects in chronic periodontitis: A case series. Jacobs J. Dent. Res. 2015;2 doi: 10.1111/jcpe.12658. - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous